Literature DB >> 3793922

Calcitonin stimulation of renal 25-hydroxyvitamin D-1 alpha-hydroxylase activity in hypophosphatemic mice. Evidence that the regulation of calcitriol production is not universally abnormal in X-linked hypophosphatemia.

T Nesbitt, B Lobaugh, M K Drezner.   

Abstract

Hypophosphatemia (Hyp) mice have defective regulation of 25(OH)D-1 alpha-hydroxylase activity in response to hypophosphatemia, hypocalcemia, and parathyroid hormone (PTH) administration. However, recent observations support the existence of anatomically distinct, independently regulated renal 1 alpha-hydroxylase systems in mammalian proximal convoluted and straight tubules. To more completely define the extent of the 1 alpha-hydroxylase regulatory defect in Hyp-mice, we compared enzyme maximum velocity in normal and mutants after infusion of calcitonin. Upon stimulation, renal 1 alpha-hydroxylase activity increased to similar levels in normal and Hyp-mouse renal homogenates. Moreover, time-course and dose-dependence studies revealed similar patterns of response in the animal models. Subsequently, we examined whether PTH and calcitonin stimulatory effects on enzyme activity are mediated through different mechanisms. In both animal models administration of PTH and calcitonin increased enzyme activity to levels greater than those obtained after maximal stimulation by either hormone alone, consistent with additive effects. These observations indicate that a calcitonin-sensitive component of 1 alpha-hydroxylase is not compromised in the X-linked hypophosphatemic syndrome.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3793922      PMCID: PMC423973          DOI: 10.1172/JCI112776

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  The determination of phosphorus and phosphatase with N-phenyl-p-phenylenediamine.

Authors:  R L DRYER; A R TAMMES; J I ROUTH
Journal:  J Biol Chem       Date:  1957-03       Impact factor: 5.157

2.  Renal handling of phosphate in vivo and in vitro by the X-linked hypophosphatemic male mouse: evidence for a defect in the brush border membrane.

Authors:  H S Tenenhouse; C R Scriver; R R McInnes; F H Glorieux
Journal:  Kidney Int       Date:  1978-09       Impact factor: 10.612

3.  Effect of calcitonin on vitamin D metabolism.

Authors:  L Galante; K W Colston; S J MacAuley; I MacIntyre
Journal:  Nature       Date:  1972-08-04       Impact factor: 49.962

4.  Intracellular processes that affect renal phosphate transport.

Authors:  V W Dennis; P C Brazy
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

Review 5.  Unique hormonal regulation of vitamin D metabolism in the mammalian kidney.

Authors:  H Kawashima; K Kurokawa
Journal:  Miner Electrolyte Metab       Date:  1983

6.  Renal adaptation to phosphate deprivation in the Hyp mouse with X-linked hypophosphatemia.

Authors:  H S Tenenhouse; C R Scriver
Journal:  Can J Biochem       Date:  1979-06

7.  Abnormal regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase activity by calcium and calcitonin in renal cortex from hypophosphatemic (Hyp) mice.

Authors:  M Fukase; L V Avioli; S J Birge; L R Chase
Journal:  Endocrinology       Date:  1984-04       Impact factor: 4.736

8.  Investigation of the mechanism for abnormal renal 25-hydroxyvitamin D3-1-hydroxylase activity in the X-linked Hyp mouse.

Authors:  H S Tenenhouse
Journal:  Endocrinology       Date:  1984-08       Impact factor: 4.736

9.  Abnormal renal mitochondrial 25-hydroxyvitamin D3-1-hydroxylase activity in the vitamin D and calcium deficient X-linked Hyp mouse.

Authors:  H S Tenenhouse
Journal:  Endocrinology       Date:  1983-08       Impact factor: 4.736

10.  Abnormal parathyroid hormone stimulation of 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the hypophosphatemic mouse. Evidence for a generalized defect of vitamin D metabolism.

Authors:  T Nesbitt; M K Drezner; B Lobaugh
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

View more
  6 in total

1.  Calcitonin is a major regulator for the expression of renal 25-hydroxyvitamin D3-1alpha-hydroxylase gene in normocalcemic rats.

Authors:  T Shinki; Y Ueno; H F DeLuca; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

2.  Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect.

Authors:  T Nesbitt; T M Coffman; R Griffiths; M K Drezner
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

3.  Normal regulation of calcitriol production in Gy mice. Evidence for biochemical heterogeneity in the X-linked hypophosphatemic diseases.

Authors:  G A Davidai; T Nesbitt; M K Drezner
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

Review 4.  Pharmacological management of X-linked hypophosphataemia.

Authors:  Erik A Imel; Kenneth E White
Journal:  Br J Clin Pharmacol       Date:  2018-10-29       Impact factor: 4.335

Review 5.  FGF23, Hypophosphatemia, and Emerging Treatments.

Authors:  Erik A Imel; Andrew Biggin; Aaron Schindeler; Craig F Munns
Journal:  JBMR Plus       Date:  2019-05-13

Review 6.  New Developments in the Treatment of X-Linked Hypophosphataemia: Implications for Clinical Management.

Authors:  Vrinda Saraff; Ruchi Nadar; Wolfgang Högler
Journal:  Paediatr Drugs       Date:  2020-04       Impact factor: 3.022

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.